Search research articles
Contact Us
Filters
Showing results (111-120 of 131) with videos related to
Page
of 14
Sort By:
Thrombosis and Haemostasis
|
August 9, 2012
Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury
Wojciech Wojakowski, Michal Tendera, Wieslaw Cybulski, et al.
European Heart Journal
|
August 25, 2009
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
Marco Metra, Eric Eichhorn, William T Abraham, et al.
European Heart Journal
|
April 9, 2024
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry
Alida L P Caforio, Juan P Kaski, Juan R Gimeno, et al.
ESC Heart Failure
|
October 23, 2020
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes
Jozef Bartunek, Andre Terzic, Beth A Davison, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 9, 2020
Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry
Juan R Gimeno, Perry M Elliott, Luigi Tavazzi, et al.
Cardiology Journal
|
September 14, 2018
Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trial
Tomasz Jadczyk, Joanna Ciosek, Aleksandra Michalewska-Wludarczyk, et al.
ESC Heart Failure
|
August 9, 2020
ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients
Tiina Heliö, Perry Elliott, Juha W Koskenvuo, et al.
JACC. Cardiovascular Interventions
|
February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)
Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
American Heart Journal
|
October 16, 2020
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction
C Michael Gibson, John J P Kastelein, Adam T Phillips, et al.
The Lancet. Diabetes & Endocrinology
|
September 18, 2017
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
Rury R Holman, Ruth L Coleman, Juliana C N Chan, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 131) with videos related to
Sort By:
Page
of 14
Thrombosis and Haemostasis
|
August 9, 2012
Effects of intracoronary delivery of allogenic bone marrow-derived stem cells expressing heme oxygenase-1 on myocardial reperfusion injury
Wojciech Wojakowski, Michal Tendera, Wieslaw Cybulski, et al.
European Heart Journal
|
August 25, 2009
Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure: the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials
Marco Metra, Eric Eichhorn, William T Abraham, et al.
European Heart Journal
|
April 9, 2024
Endomyocardial biopsy: safety and prognostic utility in paediatric and adult myocarditis in the European Society of Cardiology EURObservational Research Programme Cardiomyopathy and Myocarditis Long-Term Registry
Alida L P Caforio, Juan P Kaski, Juan R Gimeno, et al.
ESC Heart Failure
|
October 23, 2020
Cardiopoietic stem cell therapy in ischaemic heart failure: long-term clinical outcomes
Jozef Bartunek, Andre Terzic, Beth A Davison, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
October 9, 2020
Prospective follow-up in various subtypes of cardiomyopathies: insights from the ESC EORP Cardiomyopathy Registry
Juan R Gimeno, Perry M Elliott, Luigi Tavazzi, et al.
Cardiology Journal
|
September 14, 2018
Effects of trans-endocardial delivery of bone marrow-derived CD133+ cells on angina and quality of life in patients with refractory angina: A sub-analysis of the REGENT-VSEL trial
Tomasz Jadczyk, Joanna Ciosek, Aleksandra Michalewska-Wludarczyk, et al.
ESC Heart Failure
|
August 9, 2020
ESC EORP Cardiomyopathy Registry: real-life practice of genetic counselling and testing in adult cardiomyopathy patients
Tiina Heliö, Perry Elliott, Juha W Koskenvuo, et al.
JACC. Cardiovascular Interventions
|
February 23, 2010
Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events)
Gilles Montalescot, Stephen G Ellis, Mark A de Belder, et al.
American Heart Journal
|
October 16, 2020
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction
C Michael Gibson, John J P Kastelein, Adam T Phillips, et al.
The Lancet. Diabetes & Endocrinology
|
September 18, 2017
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
Rury R Holman, Ruth L Coleman, Juliana C N Chan, et al.
Page
of 14